redcap test survey cannot retake remove participant

We selected the online electronic data capture software REDCap (Research Electronic Data Capture), primarily because we had immediate access through our institution and our team had experience using this platform. We therefore planned for trials that would be entirely internet-based, with self-screening and a data-collection system that was flexible as the situation developed. We were all suddenly working remotely, so we had limited face-to-face interaction with each other, much less with potential participants. At the onset of the pandemic, all interpersonal interaction was dramatically restricted, including within our research team. From the outset we knew that these trials needed to be pragmatic since the virus was completely novel and healthcare experts were continuously learning about its behavior and effects. Protocols to investigate the drug as an early outpatient treatment for COVID-19 and as a pre-exposure prophylaxis (PrEP) followed shortly thereafter.Īt the same time, we designed and built databases for electronic data capture for these three outpatient trials. Within 8 days we had drafted and received IRB approval for a protocol to investigate hydroxychloroquine as a possible prophylaxis for those who had been recently exposed to the virus.

Our team of researchers quickly prioritized our efforts and resources to respond to the public health crisis. The novelty of this disease and its level of impact required immediate and rapid research to test options for mitigation, including clinical trials of potential prophylaxis and treatment.

The coronavirus disease 2019 (COVID-19) was declared a global pandemic by the WHO on March 11, 2020.

Redcap test survey cannot retake remove participant